Navigation Links
Reportlinker Adds Gene Therapy - technologies, markets and companies
Date:12/21/2010

therapy for genetic cardiovascular disorders 317

Genetic disorders predisposing to atherosclerosis 317

Familial hypercholesterolemia (FH) 317

Apolipoprotein E (apoE) deficiency 319

Hypertension 319

Genetic factors for myocardial infarction 320

Acquired cardiovascular diseases 320

Coronary artery disease with angina pectoris 320

Ad5FGF-4 320

Ischemic heart disease with myocardial infarction 321

Myocardial repair with IGF-1 therapy 322

Metalloproteinase-2 inhibitor gene therapy 322

Congestive heart failure 323

Rationale of gene therapy in CHF 323

Beta-ARKct gene therapy 323

Intracoronary adenovirus-mediated gene therapy for CHF 324

AAV-mediated gene transfer for CHF 324

AngioCell gene therapy for CHF 325

nNOS gene transfer in CHF 325

Cardiomyopathies 325

Cardiac conduction disturbances 326

Gene transfer approaches for biological pacemakers 326

Genetically engineered biological pacemakers 326

Gene therapy and heart transplantation 327

Peripheral arterial disease 327

Incidence and clinical features 327

Current management 328

Gene therapy for peripheral arterial disease 328

Angiogenesis by gene therapy 328

HIF-1a gene therapy for peripheral arterial disease 328

HGF gene therapy for peripheral arterial disease 329

Ischemic neuropathy secondary to peripheral arterial disease 329

Prevention of restenosis after angioplasty 330

Antisense approaches 330

Gene therapy to prevent restenosis after angioplasty 330

Techniques of gene therapy for restenosis 332

NOS gene therapy for restenosis 332

hTIMP-1 gene therapy to prevent intimal hyperplasia 333

Maintaining vascular patency after surgery 333

Companies involved in gene therapy of cardiovascular diseases 334

Future prospects of gene therapy of cardiovascu
'/>"/>

SOURCE Reportlinker
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21

Related biology technology :

1. Reportlinker Adds Molecular Diagnostics - Technologies, Markets and Companies
2. Reportlinker Adds Nanobiotechnologies- applications, markets and companies
3. Reportlinker Adds 2010 Membrane and Separation Technology Research Review
4. Reportlinker Adds Nanobiotechnology: Applications and Global Markets
5. Reportlinker Adds Chinese Markets for Biotechnology
6. Reportlinker Adds Merck KGaA: PharmaVitae Profile
7. Reportlinker Adds Global Bladder Cancer Therapeutics Industry
8. Reportlinker Adds Global Anticoagulants Industry
9. Reportlinker Adds Global Specialty Enzymes Industry
10. Reportlinker Adds Biomarkers - Technologies, Markets And Companies
11. Reportlinker Adds Next Generation U.S. and E.U. Biomaterials/BioMedical Devices: Market Trends & Commercial Implications
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/22/2014)... 22, 2014  ( www.competitivehealth.com ) — Competitive Health ... bill review and advocacy service, has signed an agreement ... Savings discount health services marketplace. 63% of ... than they expected to pay. As part of an ... WellCard Savings is pleased to offer medical bill review ...
(Date:12/19/2014)... 2014 Charm Sciences is pleased to ... Detection of Aflatoxin M1 in raw commingled milk is ... party validation. The peer reviewed report of the validation ... for Agricultural and Fisheries Research (ILVO-T&V) has been published ... B1, the most toxic aflatoxin and a known carcinogen, ...
(Date:12/19/2014)... , Dec. 19, 2014 Decision Resources Group ... grow at a 12 percent compound annual growth rate ... the aging population and the increasing adoption of dental ... will also spur demand for dental biomaterials ... implant and periodontal treatments. Other key findings ...
(Date:12/19/2014)... Ed Bilsky, Ph.D., vice president for ... Excellence in the Neurosciences (CEN), and professor of pharmacology ... as a member of the prestigious Dana Alliance for ... Maine to receive this honor. , The Dana ... the Dana Foundation. Its mission is to advance ...
Breaking Biology Technology:WellCard Savings Announces CoPatient Medical Bill Review Service for Members 2Charm Sciences Achieves Independent Validation of First 15 Minute Quantitative Screening Method for Aflatoxin M1 2Latin American Dental Biomaterial Market Will Expand at a 12 Percent Annual Growth Rate Through 2023 2Latin American Dental Biomaterial Market Will Expand at a 12 Percent Annual Growth Rate Through 2023 3UNE's Ed Bilsky Named Member of Dana Alliance for Brain Initiatives 2UNE's Ed Bilsky Named Member of Dana Alliance for Brain Initiatives 3
... a provider of electronic parts catalogs and related technology ... and record net income for the fiscal year ended July ... million, a 2% increase from revenues of $13.4 million in ... $0.32 per diluted share, from operating income of $1.3 million ...
... and Milwaukee officials on Wednesday announced plans to launch ... network accessible to all residents. , ,The Milwaukee Wireless ... large city in America, built at no cost to ... , ,"This initiative constitutes a multi-million dollar private investment, ...
... is critical to any new medical technology or treatment's ... as determinative. , ,"Coverage" is whether there will ... is how much payment there will be if there ... analyses in their evaluation of new products and, depending ...
Cached Biology Technology:Milwaukee announces citywide wireless initiative 2On track with the FDA -- But what about your coverage and reimbursement strategy? 2On track with the FDA -- But what about your coverage and reimbursement strategy? 3On track with the FDA -- But what about your coverage and reimbursement strategy? 4
(Date:12/5/2014)... Dec. 4, 2014  Tute Genomics, a leader in ... in Series A1 funding led by UK-based Eurovestech. Peak ... in the investment round. "We are at ... adopts next-generation sequencing and seeks new approaches for the ... Robison , MD MBA, and CEO of Tute Genomics. ...
(Date:11/21/2014)... November 18, 2014 According to ... by Systems (Video, RFID, Access Control, Intrusion Detection, Parking ... Banks, Government), Component Service Geography - Global Forecasts to ... is projected to be around $25 Billion in 2014 ... growing at a CAGR of 8.69%. Browse ...
(Date:11/21/2014)... 2014   Atmel® Corporation (NASDAQ: ... touch technology solutions, today launched the industry,s first family ... widest V cc range from 1.7V to 5.5V. ... I 2 C bus communication speeds, and are available ... them ideal for consumer, industrial, computer, and medical applications. ...
Breaking Biology News(10 mins):Tute Genomics Raises $2.3 Million to Scale Up Cloud-Based Genome Analytics and Accelerate Personalized Medicine 2Tute Genomics Raises $2.3 Million to Scale Up Cloud-Based Genome Analytics and Accelerate Personalized Medicine 3Industrial Security Systems Market Worth $38 Billion by 2020 2Industrial Security Systems Market Worth $38 Billion by 2020 3Atmel Launches Industry's First Wide-V(cc) Low-Power Temperature Sensor Family 2Atmel Launches Industry's First Wide-V(cc) Low-Power Temperature Sensor Family 3Atmel Launches Industry's First Wide-V(cc) Low-Power Temperature Sensor Family 4
... Neagh, has lost more than three quarters of its overwintering ... study by Quercus, Northern Ireland,s Centre for Biodiversity and Conservation ... lake for the winter months has dropped from 100,000 to ... research, published in the journal Freshwater Biology , found ...
... Munich, November 13, 2013 - Elsevier, a world-leading provider ... is pleased to announce the launch of the new ... aim of Photoacoustics is to publish original ... field of photoacoustics (optoacoustics) and thermoacoustics. Research in this ...
... , Nov. 13, 2013  Baxter International Inc. today announced ... trial of BAX 855, an investigational extended half-life, recombinant ... trial is aimed at assessing the efficacy of the ... prophylaxis and on-demand treatment schedules, and will also evaluate ...
Cached Biology News:Largest lake in Britain and Ireland has lost three-quarters of winter water birds 2Elsevier launches new open access journal: Photoacoustics 2Baxter Completes Enrollment In Phase III Clinical Trial Of BAX 855, Extended Half-life Recombinant FVIII For Hemophilia A 2Baxter Completes Enrollment In Phase III Clinical Trial Of BAX 855, Extended Half-life Recombinant FVIII For Hemophilia A 3Baxter Completes Enrollment In Phase III Clinical Trial Of BAX 855, Extended Half-life Recombinant FVIII For Hemophilia A 4Baxter Completes Enrollment In Phase III Clinical Trial Of BAX 855, Extended Half-life Recombinant FVIII For Hemophilia A 5Baxter Completes Enrollment In Phase III Clinical Trial Of BAX 855, Extended Half-life Recombinant FVIII For Hemophilia A 6
DEAD (Asp-Glu-Ala-Asp) box polypeptide 5...
...
RayBio L Series 507: RayBio Label-based Antibody Array I (1 glass slide with 2 subarrays) Class: Antibody Array Products Product Group: Antibody Array...
Rat CXCL7/Thymus Chemokine-1 DuoSet Economy Pack, 45 Plate...
Biology Products: